PLoS ONE (Jan 2014)

Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice.

  • Yosuke Kikuchi,
  • Ayami Kunitoh-Asari,
  • Katsuyuki Hayakawa,
  • Shinjiro Imai,
  • Kenji Kasuya,
  • Kimio Abe,
  • Yu Adachi,
  • Shin-Ichi Fukudome,
  • Yoshimasa Takahashi,
  • Satoshi Hachimura

DOI
https://doi.org/10.1371/journal.pone.0086416
Journal volume & issue
Vol. 9, no. 1
p. e86416

Abstract

Read online

The mucosal immune system provides the first line of defense against inhaled and ingested pathogenic microbacteria and viruses. This defense system, to a large extent, is mediated by the actions of secretory IgA. In this study, we screened 140 strains of lactic acid bacteria for induction of IgA production by murine Peyer's patch cells. We selected one strain and named it Lactobacillus plantarum AYA. We found that L. plantarum AYA-induced production of IL-6 in Peyer's patch dendritic cells, with this production promoting IgA(+) B cells to differentiate into IgA-secreting plasma cells. We also observed that oral administration of L. plantarum AYA in mice caused an increase in IgA production in the small intestine and lung. This production of IgA correlated strongly with protective ability, with the treated mice surviving longer than the control mice after lethal influenza virus infection. Our data therefore reveals a novel immunoregulatory role of the L. plantarum AYA strain which enhances mucosal IgA production and provides protection against respiratory influenza virus infection.